Track 5: Cardio-Oncology – Where Cancer Care Meets Cardiovascular Precision

5th World Cardiology and Cardiovascular Diseases Conference | March 04–06, 2026 | Dubai, UAE

As cancer survival rates continue to rise, so too does a growing and urgent need to address the cardiovascular side effects of cancer therapies. At the intersection of oncology and cardiology lies the rapidly evolving field of Cardio-Oncology—the focus of Track 5 at the upcoming 5th World Cardiology and Cardiovascular Diseases Conference in Dubai, UAE.

This dedicated track offers a critical platform to explore how cancer treatments impact the heart, and how healthcare professionals can work together to protect both survival and quality of life for patients.

---

The Rising Relevance of Cardio-Oncology

Life-saving cancer treatments such as chemotherapy, immunotherapy, radiation, and targeted agents often come with unintended cardiovascular risks—ranging from arrhythmias and hypertension to heart failure and myocardial ischemia. With the number of cancer survivors growing worldwide, managing these cardiovascular effects has become a priority in long-term cancer care.

---

What Track 5 Will Cover

1. Understanding Cardiotoxicity
Explore the latest research on how common cancer therapies—including anthracyclines, HER2 inhibitors, and immune checkpoint inhibitors—impact cardiac function. Experts will discuss early identification and mechanisms of cardiotoxicity.

2. Risk Stratification and Surveillance
Learn how to assess baseline cardiac risk before treatment and monitor high-risk patients throughout their oncology journey using biomarkers, imaging (such as echocardiography and cardiac MRI), and clinical algorithms.

3. Cardio-Protective Strategies
Sessions will highlight best practices for preventing and managing treatment-induced cardiac dysfunction, including use of beta-blockers, ACE inhibitors, and novel protective agents.

4. Multidisciplinary Team Approaches
Discover how collaboration between oncologists, cardiologists, pharmacists, and primary care physicians can create seamless cardio-oncology pathways that reduce risk and enhance patient outcomes.

5. Cardio-Oncology in Survivorship
Address long-term follow-up care for cancer survivors, focusing on heart health monitoring, lifestyle modification, and managing delayed cardiac effects years after treatment.

6. Pediatric and Young Adult Considerations
Special discussions will spotlight cardio-oncology concerns in pediatric and adolescent cancer survivors—whose risks span decades post-treatment.

---

Why Attend Track 5?

Whether you're a cardiologist, oncologist, internist, nurse, or researcher, Track 5: Cardio-Oncology is essential for understanding one of the most pressing dual-discipline challenges in modern medicine. This track empowers attendees with knowledge, tools, and partnerships to protect patients’ hearts without compromising their cancer care.

---

Dubai: Bridging Disciplines, Building Futures

Set against the vibrant backdrop of Dubai, a global hub for innovation and medical collaboration, this conference provides a unique opportunity to network, learn, and lead the way in integrated patient care.

---

Final Thoughts

The heart and the fight against cancer are more connected than ever. As survival rates rise, so must our commitment to holistic care. Track 5: Cardio-Oncology is your chance to be part of a movement that is redefining survivorship—protecting lives, one heartbeat at a time.

🫀💫 Join us March 04–06, 2026, in Dubai.
Where cardiology and oncology unite for a healthier tomorrow.